ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 29 filers reported holding ALLENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,000 | -14.3% | 33,000 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -50.0% | 33,000 | +43.5% | 0.00% | – |
| Q4 2021 | $14,000 | -33.3% | 23,000 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -30.0% | 23,000 | 0.0% | 0.00% | – |
| Q2 2021 | $30,000 | -6.2% | 23,000 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | +39.1% | 23,000 | +27.8% | 0.00% | – |
| Q4 2020 | $23,000 | -14.8% | 18,000 | 0.0% | 0.00% | – |
| Q3 2020 | $27,000 | -15.6% | 18,000 | -10.0% | 0.00% | – |
| Q2 2020 | $32,000 | +190.9% | 20,000 | +81.8% | 0.00% | – |
| Q1 2020 | $11,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,790,964 | $3,572,000 | 2.49% |
| AIGH Capital Management LLC | 2,000,000 | $2,560,000 | 1.04% |
| Worth Venture Partners, LLC | 510,200 | $653,000 | 0.52% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $4,263,000 | 0.33% |
| SABBY MANAGEMENT, LLC | 269,836 | $345,000 | 0.07% |
| Anson Funds Management LP | 217,251 | $278,000 | 0.06% |
| Golden Green, Inc. | 39,000 | $50,000 | 0.05% |
| Point72 Asset Management, L.P. | 4,000,000 | $5,120,000 | 0.02% |
| PFM Health Sciences, LP | 284,285 | $364,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,800 | $203,000 | 0.00% |